198 related articles for article (PubMed ID: 9470803)
1. Review of recent trials of chemotherapy for advanced breast cancer: studies excluding taxanes.
Clemons M; Leahy M; Valle J; Jayson G; Ranson M; Hayes S; Howell A
Eur J Cancer; 1997 Nov; 33(13):2171-82. PubMed ID: 9470803
[No Abstract] [Full Text] [Related]
2. High-dose chemotherapy and autologous stem cell transplantation for breast cancer.
Weaver CH; Birch R; Schwartzberg LS; West WH
Cancer Treat Res; 1995; 76():59-85. PubMed ID: 7577345
[No Abstract] [Full Text] [Related]
3. Breast cancer highlights.
Kuter I
Oncologist; 1999; 4(4):299-308. PubMed ID: 10476541
[No Abstract] [Full Text] [Related]
4. Drug treatments for adjuvant chemotherapy in breast cancer: recent trials and future directions.
Dang CT
Expert Rev Anticancer Ther; 2006 Mar; 6(3):427-36. PubMed ID: 16503859
[TBL] [Abstract][Full Text] [Related]
5. [San Antonio Breast Cancer Symposium 2003. New therapeutic prospects in the treatment of early-stage breast cancer].
Montemurro F
Tumori; 2004; 90(1):suppl 1-16. PubMed ID: 15143995
[No Abstract] [Full Text] [Related]
6. [General evaluation of adjuvant chemotherapy trials in breast cancer (excluding the Milan trial)].
Gest J
Bull Cancer; 1984; 71(4):336-44. PubMed ID: 6388672
[TBL] [Abstract][Full Text] [Related]
7. Adjuvant taxanes in the treatment of breast cancer: no longer at the tip of the iceberg.
Dang C; Hudis C
Clin Breast Cancer; 2006 Apr; 7(1):51-8. PubMed ID: 16764744
[TBL] [Abstract][Full Text] [Related]
8. High-dose chemotherapy with autologous stem cell support for breast cancer: a review of the Dana-Farber Cancer Institute/Beth Israel Hospital experience.
Ayash LJ; Elias A; Wheeler C; Tepler I; Schwartz G; Schnipper L; Frei E; Antman K
J Hematother; 1993; 2(4):507-11. PubMed ID: 7916250
[TBL] [Abstract][Full Text] [Related]
9. Dose-dense chemotherapy for primary breast cancer.
Kümmel S; Rezai M; Kimmig R; Schmid P
Curr Opin Obstet Gynecol; 2007 Feb; 19(1):75-81. PubMed ID: 17218856
[TBL] [Abstract][Full Text] [Related]
10. [Taxanes as adjuvants in breast cancer. What repercussions will this have in clinical practice?].
Mosconi AM; Montedoro M
Suppl Tumori; 2004; 3(4):S18-20. PubMed ID: 15206203
[No Abstract] [Full Text] [Related]
11. Re: randomized trial of high-dose chemotherapy and blood cell autografts for high-risk primary breast carcinoma.
Pedrazzoli P; Bianchi AS; Renga M; Siena S
J Natl Cancer Inst; 2000 Aug; 92(15):1271-2. PubMed ID: 10922417
[No Abstract] [Full Text] [Related]
12. [Relation dose efficacy in chemotherapy: the example of breast cancer].
Chevallier B; Perrocheau G
Bull Cancer; 1995; 82 Suppl 1():9s-15s. PubMed ID: 7626858
[TBL] [Abstract][Full Text] [Related]
13. Adjuvant therapy for all patients with breast cancer?
Lippman ME; Hayes DF
J Natl Cancer Inst; 2001 Jan; 93(2):80-2. PubMed ID: 11208870
[No Abstract] [Full Text] [Related]
14. [Taxanes in metastatic breast cancer. An analysis of a systematic Cochrane review].
Nielsen DL; Kamby C
Ugeskr Laeger; 2006 Sep; 168(37):3117-20. PubMed ID: 16999914
[No Abstract] [Full Text] [Related]
15. Trial data lacking for elderly patients with breast cancer.
Nelson NJ
J Natl Cancer Inst; 2000 Dec; 92(24):1968-9. PubMed ID: 11121451
[No Abstract] [Full Text] [Related]
16. Are there still reasons to believe that high-dose chemotherapy has a role in breast cancer management?
Castagna L; Martino M
Bone Marrow Transplant; 2013 Feb; 48(2):305. PubMed ID: 22750999
[No Abstract] [Full Text] [Related]
17. Systematic review of taxane-containing versus non-taxane-containing regimens for adjuvant and neoadjuvant treatment of early breast cancer.
Nowak AK; Wilcken NR; Stockler MR; Hamilton A; Ghersi D
Lancet Oncol; 2004 Jun; 5(6):372-80. PubMed ID: 15172358
[TBL] [Abstract][Full Text] [Related]
18. [The optimal duration of adjuvant therapy in breast cancer: what kind of evidence? Chemotherapy: the example of clinical studies].
Sdrobolini A
Suppl Tumori; 2004; 3(4):S77-8. PubMed ID: 15206220
[No Abstract] [Full Text] [Related]
19. Adjuvant therapy for node-negative breast cancer: a proactive view.
Glick JH
Important Adv Oncol; 1990; ():183-97. PubMed ID: 2182518
[No Abstract] [Full Text] [Related]
20. Taxanes as adjuvant for breast cancer.
Goldhirsch A; Francis P; Castiglione-Gertsch M; Gelber RD; Coates AS
Lancet; 2000 Aug; 356(9228):507-8. PubMed ID: 10981914
[No Abstract] [Full Text] [Related]
[Next] [New Search]
